Cite
Resolution of subclinical porphyria cutanea tarda after hepatitis C eradication with direct-acting anti-virals
MLA
Anna Pocurull, et al. “Resolution of Subclinical Porphyria Cutanea Tarda after Hepatitis C Eradication with Direct-Acting Anti-Virals.” Alimentary Pharmacology & Therapeutics, vol. 51, Apr. 2020, pp. 968–73. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....34aed095d0fe636a5e628bb67b5fa1e7&authtype=sso&custid=ns315887.
APA
Anna Pocurull, Jordi To-Figueras, Xavier Forns, Paula Aguilera, Sabela Lens, Zoe Mariño, Celia Badenas, Rafael Oliva, Sergio Rodríguez-Tajes, Concepció Bartres, & Lydia Sastre. (2020). Resolution of subclinical porphyria cutanea tarda after hepatitis C eradication with direct-acting anti-virals. Alimentary Pharmacology & Therapeutics, 51, 968–973.
Chicago
Anna Pocurull, Jordi To-Figueras, Xavier Forns, Paula Aguilera, Sabela Lens, Zoe Mariño, Celia Badenas, et al. 2020. “Resolution of Subclinical Porphyria Cutanea Tarda after Hepatitis C Eradication with Direct-Acting Anti-Virals.” Alimentary Pharmacology & Therapeutics 51 (April): 968–73. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....34aed095d0fe636a5e628bb67b5fa1e7&authtype=sso&custid=ns315887.